Diamicron MR達美康MR

Diamicron MR

gliclazide

Manufacturer:

Servier

Distributor:

Zuellig
/
Agencia Lei Va Hong
Concise Prescribing Info
Contents
Gliclazide
Indications/Uses
NIDDM in adult when dietary measures, physical exercise & wt loss alone are not sufficient to control blood glucose.
Dosage/Direction for Use
Initially 30 mg daily, may be used as maintenance dose if blood glucose is effectively controlled. May be increased to 60, 90 or 120 mg daily in successive steps if blood glucose is not adequately controlled. The interval between each dose increment should be at least 1 mth. Max: 120 mg daily.
Administration
Should be taken with food: Take immediately before meals. Swallow whole, do not chew/crush.
Contraindications
Hypersensitivity to gliclazide, other sulfonylurea or sulfonamides. Type I diabetes; diabetic pre-coma & coma, diabetic ketoacidosis. Severe renal or hepatic insufficiency. Treatment w/ miconazole. Lactation.
Special Precautions
Hypoglycaemia which may occur due to low-calorie diets, prolonged or strenuous exercise, alcohol intake, use w/ other hypoglycaemic agents, or presence of risk factors (eg, patient refuses or unable to cooperate, malnutrition, irregular mealtimes, imbalance between physical exercise & carbohydrate intake, renal & severe hepatic insufficiency, overdose, thyroid disorders, hypopituitarism & adrenal insufficiency). Inform patient of the importance of following dietary advice, taking regular exercise & regular monitoring of blood glucose levels. St. John's wort, fever, trauma, infection or surgery may affect blood glucose control. Reports of dysglycaemia w/ concomitant use of fluoroquinolones. Patients w/ G6PD-deficiency. Porphyric patients. Caution in driving or operating machinery. Avoid use during pregnancy. Safety & efficacy in childn & adolescents have not been established. 60-mg tab: Do not administer to patients w/ rare hereditary problems of galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption.
Adverse Reactions
Hypoglycaemia, GI disturbances (abdominal pain, nausea, vomiting, dyspepsia, diarrhoea, constipation).
Drug Interactions
Increased risk of hypoglycaemia w/ miconazole, phenylbutazone, alcohol, other antidiabetic agents (insulins, acarbose, metformin, thiazolidinediones, dipeptidyl peptidase-4 inhibitors, GLP-1 receptor agonists), β-blockers, fluconazole, ACE inhibitors (captopril, enalapril), H2-receptor antagonists, MAOIs, sulfonamides, clarithromycin, NSAIDs. Increased blood glucose levels w/ danazol, chlorpromazine at high doses, glucocorticoids, ritodrine, salbutamol, terbutaline, St John's wort prep. Risk of dysglycaemia w/ fluoroquinolones. Potentiation of anticoagulant therapy (eg, warfarin).
MIMS Class
Antidiabetic Agents
ATC Classification
A10BB09 - gliclazide ; Belongs to the class of sulfonylureas. Used in the treatment of diabetes.
Presentation/Packing
Form
Diamicron MR modified-release tab 30 mg
Packing/Price
30's
Form
Diamicron MR modified-release tab 60 mg
Packing/Price
30's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in